Loading
Pawel Kalinski is an immunologist reprogramming tumour microenvironments so T cells can enter.
Pawel Kalinski is Vice Chair for Translational Research in the Department of Medicine and Chief of Translational Immuno-Oncology at Roswell Park Comprehensive Cancer Center. He is an immunologist known for reprogramming tumour microenvironments so that T cells can enter, developing chemokine-modulating regimens that combine interferon, TLR3 agonists and COX-2 inhibition, alongside dendritic cell vaccines. His selected paper reviews chemokine modulation to enhance T cell infiltration of tumours. He continues to work on converting immune-excluded tumours to respond to checkpoint inhibitors.
| Title | Journal | Year |
|---|---|---|
| Chemokine modulation to enhance T cell infiltration of tumors | Cancer Immunology Research | 2019 |
Shares Cancer Immunology Research, Immune checkpoint inhibitors.
Shares Cancer Immunology Research, Immune checkpoint inhibitors.
Shares Cancer Immunology Research, Immune checkpoint inhibitors.
Shares Roswell Park Comprehensive Cancer Center, Immune checkpoint inhibitors.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/